NYSE:CLB
Core Laboratories NV Stock News
$15.70
-0.0100 (-0.0637%)
At Close: May 02, 2024
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
12:32pm, Thursday, 25'th Apr 2024
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
12:01pm, Thursday, 25'th Apr 2024
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
What Makes Core Laboratories (CLB) a New Strong Buy Stock
01:01pm, Thursday, 18'th Apr 2024
Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
11:07am, Wednesday, 17'th Apr 2024
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term
10:46am, Friday, 29'th Mar 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line
11:16am, Thursday, 01'st Feb 2024
Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings
08:01pm, Wednesday, 31'st Jan 2024
While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metri
Core Laboratories (CLB) Q4 Earnings Miss Estimates
07:46pm, Wednesday, 31'st Jan 2024
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago.
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
01:17pm, Wednesday, 10'th Jan 2024
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating).
February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
05:26am, Tuesday, 09'th Jan 2024
In the investment space, uncovering stocks to sell with potential pitfalls is as crucial as identifying opportunities. This comprehensive review zooms in on the recent moves of three prominent compani
3 Oil Stocks to Sell in January Before They Crash and Burn
03:14pm, Tuesday, 02'nd Jan 2024
Throughout 2023, energy companies struggled compared to the large rally in 2021 and 2022. The benchmark for energy companies is the Energy Select Sector SPDR Fund (NYSEARCA: XLE ), which had a share p
Down -7.87% in 4 Weeks, Here's Why Core Laboratories (CLB) Looks Ripe for a Turnaround
11:18am, Thursday, 07'th Dec 2023
Core Laboratories (CLB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings es
3 Energy Stocks Priced Under $100 to Bet on Right Away
10:32am, Thursday, 07'th Dec 2023
It's an opportune moment for investors to incorporate energy stocks like The Williams Companies, Inc. (WMB), Matador Resources Company (MTDR) and Core Laboratories Inc. (CLB) in their portfolio.
Core Laboratories (CLB) Q3 Earnings Top, Revenues Miss
09:48am, Friday, 03'rd Nov 2023
Core Laboratories (CLB) anticipates revenues in the range of $125-$132 million and operating income in the band of $13.8-$17.3 million for the fourth quarter of 2023. It also expects earnings per shar
Core Laboratories (CLB) Reports Q3 Earnings: What Key Metrics Have to Say
09:02pm, Wednesday, 01'st Nov 2023
Although the revenue and EPS for Core Laboratories (CLB) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with